Cargando…

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review

BACKGROUND AND PURPOSE: Gadolinium based contrast agents (GBCAs) are widely used in magnetic resonance imaging, but recently, high signal intensity in the cerebellum structures was reported after repeated administrations of contrast- enhanced magnetic resonance images. The aim of this systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Olchowy, Cyprian, Cebulski, Kamil, Łasecki, Mateusz, Chaber, Radosław, Olchowy, Anna, Kałwak, Krzysztof, Zaleska-Dorobisz, Urszula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302442/
https://www.ncbi.nlm.nih.gov/pubmed/28187173
http://dx.doi.org/10.1371/journal.pone.0171704
_version_ 1782506544883040256
author Olchowy, Cyprian
Cebulski, Kamil
Łasecki, Mateusz
Chaber, Radosław
Olchowy, Anna
Kałwak, Krzysztof
Zaleska-Dorobisz, Urszula
author_facet Olchowy, Cyprian
Cebulski, Kamil
Łasecki, Mateusz
Chaber, Radosław
Olchowy, Anna
Kałwak, Krzysztof
Zaleska-Dorobisz, Urszula
author_sort Olchowy, Cyprian
collection PubMed
description BACKGROUND AND PURPOSE: Gadolinium based contrast agents (GBCAs) are widely used in magnetic resonance imaging, but recently, high signal intensity in the cerebellum structures was reported after repeated administrations of contrast- enhanced magnetic resonance images. The aim of this systematic review was to investigate the association between increased signal intensity in the dentate nucleus and globus pallidus in the brain and repeated administrations of GBCAs. Additionally, we focused on possible short- and long-term consequences of gadolinium use in those patients. METHODS: Systematic review of retrospective investigations in PubMed and Medline was performed in July 2016. Primary outcomes included the presence of increased signal intensity within the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in patients following administrations of GBCAs. Two independent reviewers were responsible for search and data extraction. RESULTS: 25 publications satisfied inclusion criteria (19 magnetic resonance images analyses, 3 case reports; 3 autopsy studies). Magnetic resonance images of 1247 patients with increased signal intensity on unenhanced T1-weighted MR images were analyzed as well as tissue specimens from 27 patients. Signal intensity correlated positively with the exposure to GBCAs and was greater after serial administrations of linear nonionic than cyclic contrast agents. Gadolinium was detected in all tissue examinations. CONCLUSIONS: High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted magnetic resonance images were associated with previous administration of GBCAs. Signal intensity correlated negatively with stability of contrast agents. Clinical significance of gadolinium deposition in the brain remains unclear. There is a strong need for further research to identify type of gadolinium deposited in the brain as well as to gather knowledge about long-term consequences.
format Online
Article
Text
id pubmed-5302442
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53024422017-02-28 The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review Olchowy, Cyprian Cebulski, Kamil Łasecki, Mateusz Chaber, Radosław Olchowy, Anna Kałwak, Krzysztof Zaleska-Dorobisz, Urszula PLoS One Research Article BACKGROUND AND PURPOSE: Gadolinium based contrast agents (GBCAs) are widely used in magnetic resonance imaging, but recently, high signal intensity in the cerebellum structures was reported after repeated administrations of contrast- enhanced magnetic resonance images. The aim of this systematic review was to investigate the association between increased signal intensity in the dentate nucleus and globus pallidus in the brain and repeated administrations of GBCAs. Additionally, we focused on possible short- and long-term consequences of gadolinium use in those patients. METHODS: Systematic review of retrospective investigations in PubMed and Medline was performed in July 2016. Primary outcomes included the presence of increased signal intensity within the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in patients following administrations of GBCAs. Two independent reviewers were responsible for search and data extraction. RESULTS: 25 publications satisfied inclusion criteria (19 magnetic resonance images analyses, 3 case reports; 3 autopsy studies). Magnetic resonance images of 1247 patients with increased signal intensity on unenhanced T1-weighted MR images were analyzed as well as tissue specimens from 27 patients. Signal intensity correlated positively with the exposure to GBCAs and was greater after serial administrations of linear nonionic than cyclic contrast agents. Gadolinium was detected in all tissue examinations. CONCLUSIONS: High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted magnetic resonance images were associated with previous administration of GBCAs. Signal intensity correlated negatively with stability of contrast agents. Clinical significance of gadolinium deposition in the brain remains unclear. There is a strong need for further research to identify type of gadolinium deposited in the brain as well as to gather knowledge about long-term consequences. Public Library of Science 2017-02-10 /pmc/articles/PMC5302442/ /pubmed/28187173 http://dx.doi.org/10.1371/journal.pone.0171704 Text en © 2017 Olchowy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Olchowy, Cyprian
Cebulski, Kamil
Łasecki, Mateusz
Chaber, Radosław
Olchowy, Anna
Kałwak, Krzysztof
Zaleska-Dorobisz, Urszula
The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title_full The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title_fullStr The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title_full_unstemmed The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title_short The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
title_sort presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - a systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302442/
https://www.ncbi.nlm.nih.gov/pubmed/28187173
http://dx.doi.org/10.1371/journal.pone.0171704
work_keys_str_mv AT olchowycyprian thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT cebulskikamil thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT łaseckimateusz thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT chaberradosław thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT olchowyanna thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT kałwakkrzysztof thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT zaleskadorobiszurszula thepresenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT olchowycyprian presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT cebulskikamil presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT łaseckimateusz presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT chaberradosław presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT olchowyanna presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT kałwakkrzysztof presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview
AT zaleskadorobiszurszula presenceofthegadoliniumbasedcontrastagentdepositionsinthebrainandsymptomsofgadoliniumneurotoxicityasystematicreview